| Company/Division name | Innova Medical Group |
| Parent company | Pasaca Capital |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 1600 |
| Year reshoring announced: | 2021 |
| Year reshoring implemented or to be implemented: | 2021 |
| Domestically, the work will be done: | Both |
| City reshored to: | Pasadena |
| State(s) reshored to: | CA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | SARS-COV-2 rapid antigen test kit, Covid-19 test |
| What domestic positive factors made reshoring more attractive? | Impact on domestic economy, Under-utilized capacity, Other, Covid-19 |
